Colompack
Colompack S.A. is a Bogotá-based, privately held Colombian pharmaceutical CDMO founded in 1999, offering integrated maquila, R&D, stability, lab analysis, and raw materials supply services to human and veterinary pharmaceutical laboratories under INVIMA and ICA certifications.
- Company typePrivate
- Founded1999
- HeadquartersBogotá, Colombia
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Colompack does
Colompack S.A. is a privately held Colombian pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Bogotá, operating since 1999. The company provides an integrated portfolio of five services for human and veterinary pharmaceutical products: Maquila (contract manufacturing of solid, semi-solid, and liquid dosage forms including powders, tablets, hard gelatin capsules, syrups, suspensions, emulsions, creams, gels, and ointments); R&D (preformulation, formulation, reformulation, pilot batches, industrial scale-up, and technology transfer); Stability Studies (ICH-compliant pre-stability, accelerated, natural, and ongoing programs for climatic zone IV-B); Laboratory Analysis and Quality Control under Good Laboratory Practices (raw material, packaging, in-process, and finished product testing using HPLC, UV-Vis, IR, and dissolution techniques); and 360-degree Raw Materials Supply with pharmacopeial analysis. The company holds Good Manufacturing Practices (BPM) certifications from INVIMA for human products and ICA for veterinary products, plus Good Laboratory Practices (BPL) certification from INVIMA.
Colompack's business model is B2B sales-led, selling integrated services directly to pharmaceutical laboratories through direct engagement, contact forms, phone, and email. Revenue is generated through one-time maquila contracts, per-test laboratory fees, project-based stability studies and R&D engagements, and transaction fees on raw materials supply. Pricing is quote-based and not publicly disclosed. The company's stated headcount range is 101-250 employees, operating from a single Bogotá facility at Carrera 46 #20B-34. The marketed customer base includes 11 named enterprise pharmaceutical clients such as MEGALABS, Lab Bagó, GRUINFACOL, SUIPHAR INTERNACIONAL, Farma de Colombia, GIMED, IMPOFAR, Laboratorios Best, NeVox, RGB-CC, and RGB-MP, all operating primarily in the Colombian market.
The company is privately held with no disclosed funding rounds, no subsidiaries, no M&A activity, and no patents or trademarks recorded. Marketing presence is limited to a corporate website and LinkedIn profile. Operating geography is restricted to Colombia within the LATAM region, with no international expansion claims in the source material.
Colompack firmographics
Firmographics- Name
- Colompack
- Legal name
- Colompack S.A.
- Website
- https://colompack.co
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Colompack S.A. is a Bogotá-based, privately held Colombian pharmaceutical CDMO founded in 1999, offering integrated maquila, R&D, stability, lab analysis, and raw materials supply services to human and veterinary pharmaceutical laboratories under INVIMA and ICA certifications.
- Ownership category
- akta.pro rank
Colompack industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing Services
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Scientific Research and Development Services (5417)
- SIC
- Pharmaceutical Preparations (2834), Services-Medical Laboratories (8071)
- akta.pro primary industry
- GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)
- akta.pro secondary industry
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)
Keywords
Where Colompack is headquartered
LocationHeadquarters
- HQ city
- Bogotá
- HQ country
- Colombia
- HQ region
- Latin America
Offices1 record
Markets served
Colompack business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Contract Manufacturing (Maquila): Pharmaceutical manufacturing services for solid, semi-solid, and liquid dosage forms for human and veterinary use. Includes primary and secondary packaging services.
- Laboratory Testing Services: Physical-chemical analysis services including raw materials testing, packaging materials testing, finished product testing, and process/cleaning validations. Revenue generated per test or project.
- Stability Studies: Pre-stability, accelerated and natural stability, and ongoing stability studies for pharmaceutical products following ICH guidelines in climatic zone IV-B.
- Research and Development Services: New product development including preformulation, formulation, reformulation, pilot batches, industrial scale-up, and technology transfer services.
- Raw Materials Supply: Supply of pharmaceutical raw materials, active ingredients, excipients, standards, reagents, and special columns with pharmacopeial analysis.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Colompack product offering
Product offeringCore offering
Colompack S.A. provides integrated pharmaceutical services for human and veterinary products, including contract manufacturing (maquila) of solid, semi-solid, and liquid dosage forms; research and development (preformulation, formulation, pilot batches, scale-up); GLP-certified laboratory analysis and quality control; ICH-compliant stability studies; and 360-degree raw materials supply. Services span from product idea through regulatory dossier preparation.
Product overview
Colompack S.A. is a pharmaceutical contract manufacturing and services company offering an integrated portfolio of five interconnected services for human and veterinary pharmaceutical products. The core offerings include Maquila (contract manufacturing with solid, semi-solid, and liquid pharmaceutical forms), Investigación y Desarrollo (R&D for new product development), Estudios de Estabilidad (stability studies), Análisis de Laboratorio y Control de Calidad (BPL-certified laboratory analysis and quality control), and Abastecimiento de Materias Primas e Insumos (raw material supply). These services are designed to provide clients with comprehensive support from product development through manufacturing, testing, and regulatory affairs.
Differentiator
Problem solved
Functional benefit
Products and services
- Maquila (Contract Manufacturing) Comprehensive manufacturing services for pharmaceutical products for human and veterinary use, including solid forms (powders, coated and uncoated tablets, hard gelatin capsules), semi-solids (creams, gels, ointments, lotions), and liquids (syrups, solutions, suspensions, emulsions), with primary and secondary packaging capabilities for non-sterile medications.
- Investigación y Desarrollo (Research and Development) Full-spectrum pharmaceutical R&D services for new product development including preformulation, formulation, reformulation, pilot batch production, industrial scale-up, and technology transfer for human and veterinary pharmaceutical products across multiple dosage forms.
- Estudios de Estabilidad (Stability Studies) Stability testing services including pre-stability, accelerated stability (40°C – 75% RH), natural stability (30°C – 75% RH for 0-36 months), ongoing stability, and analytical technique validation, compliant with ICH guidelines in climatic zone IV-B.
- Análisis de Laboratorio y Control de Calidad (Laboratory Analysis and Quality Control) BPL-certified (Good Laboratory Practices) laboratory services for raw material analysis, packaging material testing, in-process and finished product analysis, process validation, and cleaning validation, utilizing techniques including HPLC, UV-visible spectroscopy, IR spectroscopy, and dissolution testing.
- Abastecimiento de Materias Primas e Insumos (Raw Material Supply) 360-degree raw material supply services including active pharmaceutical ingredients and excipients, standards and special reagents, special columns, and full supply chain management with pharmacopeial analysis, serving both internal maquila operations and external clients.
Quantifiable outcome
- Integrated services from R&D to regulatory affairs reduce client coordination burden
Companies that use Colompack
Customer profileNamed customers11 records
Segments1 record
Ideal customer profiles1 record
Colompack technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Colompack partnerships and signals
Strategic signalScale indicators2 records
Expansion highlights3 records
Colompack competitors and assessment
Company assessmentBroad incumbents
- Lonza Group: Global CDMO providing pharma contract manufacturing and lab services across small molecules, biologics, and cell therapies. Comparable as a regulatory-certified, capital-intensive CDMO operating at meaningfully larger scale than Colompack.
- Aenova Group: European pharmaceutical CDMO offering contract development and manufacturing for oral solids, semi-solids, and sterile dosage forms. Comparable as a broad-based CDMO with pharmaceutical manufacturing and lab testing services similar to Colompack's integrated offering.
- Recipharm: European pharmaceutical CDMO offering contract manufacturing of solid, semi-solid, and sterile dosage forms. Comparable as a large-scale contract manufacturer in the same dosage-form categories that Colompack services.
- Catalent: Global pharmaceutical CDMO offering contract development and manufacturing across oral, sterile, and biologic dosage forms. Comparable as a large-scale pharmaceutical contract manufacturer with regulatory expertise that occasionally services LATAM clients.
- Siegfried Holding: Swiss pharmaceutical CDMO offering API and finished dosage form manufacturing services globally. Comparable contract manufacturer profile with broad regulatory expertise relevant to Colompack's BPM-certified operations.
Regional players
- Eurofarma Laboratórios: Brazilian pharmaceutical manufacturer with extensive LATAM CDMO and contract manufacturing footprint. Comparable as a multi-dosage-form CDMO serving Latin American pharmaceutical clients; an indirect regional peer rather than a direct Colombian competitor.
Direct peers
- Procaps: Colombian pharmaceutical company with significant contract manufacturing capabilities in solid, semi-solid, and liquid dosage forms, serving both human and veterinary markets. Directly competes with Colompack in the domestic maquila segment for the same Colombian pharma clients.
- Tecnoquímica: One of the largest Colombian pharmaceutical manufacturers with in-house R&D, manufacturing, and regulatory services. Competes with Colompack for contract manufacturing slots in solid and liquid dosage forms within the domestic Colombian market.
Emerging players
- Laboratorios Cryopharma: Smaller Colombian pharmaceutical manufacturer with contract manufacturing capabilities for human dosage forms. Comparable as a domestic Colombian CDMO peer competing for local pharma lab business in solid and semi-solid forms.
- Gienic Laboratorios: Glenmark Colombia is part of a multinational pharma manufacturer operating in the Colombian market with solid-dose capabilities; an emerging comparable as it competes for Colombian contract manufacturing work in adjacent dosage forms.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Colompack social profiles
Digital presenceColompack compliance and trust
Trust signalCompliance2 records
Colompack financial estimates
Financial estimateRevenue estimate
Valuation estimate
Colompack leadership team
Management profileNumber of profiles
Colompack funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Colompack M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Colompack
What does Colompack do?
Colompack S.A. provides integrated pharmaceutical services for human and veterinary products, including contract manufacturing (maquila) of solid, semi-solid, and liquid dosage forms; research and development (preformulation, formulation, pilot batches, scale-up); GLP-certified laboratory analysis and quality control; ICH-compliant stability studies; and 360-degree raw materials supply. Services span from product idea through regulatory dossier preparation.
Is Colompack a public or private company?
Colompack is a private company. It is classified as unknown and is currently operating.
When was Colompack founded?
Colompack was founded in 1999. It employs 101 to 250 people.
Where is Colompack based?
Colompack is headquartered in Bogotá, Colombia, in the Latin America region.
How does Colompack make money?
Five revenue lines are on record. Contract Manufacturing (Maquila) is the primary driver. The others are laboratory Testing Services, stability Studies, research and Development Services and raw Materials Supply.
Who are Colompack's main competitors?
Broad incumbents on record are Lonza Group, Aenova Group, Recipharm, Catalent and Siegfried Holding. Eurofarma Laboratórios is listed as a regional player. Direct peers are Procaps and Tecnoquímica. Emerging players are Laboratorios Cryopharma and Gienic Laboratorios.
Does Colompack have an API?
No public API is recorded for Colompack.
What industry is Colompack in?
Colompack's product category is Pharmaceutical Contract Manufacturing Services. Its primary akta.pro industry code is HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ), with a secondary code of HLAGAAAC, Toxicology & Safety Assessment CROs (GLP). Its NAICS code is 325412 and its SIC code is 2834.